Artículos de revistas
The neonatal immune system: immunomodulation of infections in early life
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, LONDON, v. 10, n. 3, supl. 1, Part 1, pp. 289-298, MAR, 2012
Futata, Eliana Akemi
Fusaro, Ana Elisa
de Brito, Cyro Alves
Sato, Maria Notomi
The innate and adaptive immune responses in neonates are usually functionally impaired when compared with their adult counterparts. The qualitative and quantitative differences in the neonatal immune response put them at risk for the development of bacterial and viral infections, resulting in increased mortality. Newborns often exhibit decreased production of Th1-polarizing cytokines and are biased toward Th2-type responses. Studies aimed at understanding the plasticity of the immune response in the neonatal and early infant periods or that seek to improve neonatal innate immune function with adjuvants or special formulations are crucial for preventing the infectious disease burden in this susceptible group. Considerable studies focused on identifying potential immunomodulatory therapies have been performed in murine models. This article highlights the strategies used in the emerging field of immunomodulation in bacterial and viral pathogens, focusing on preclinical studies carried out in animal models with particular emphasis on neonatal-specific immune deficits.